Financhill
Sell
44

LXRX Quote, Financials, Valuation and Earnings

Last price:
$1.32
Seasonality move :
-9.17%
Day range:
$1.28 - $1.35
52-week range:
$0.28 - $1.83
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
6.70x
P/B ratio:
3.96x
Volume:
1.1M
Avg. volume:
3.2M
1-year change:
76.72%
Market cap:
$476.1M
Revenue:
$31.1M
EPS (TTM):
-$0.19

Earnings Data

Next earnings date for LXRX
Mar 05
2026
Most recent earnings per share
-$0.04
Beat by $0.03
(Nov 6/2025)
Consensus Estimate
-$0.07
(Nov 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

LXRX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2026 Q1 $5.7M -- -- -$0.07 --
03/05/2026 Q4 $3.1M -- -- -$0.07 --
11/06/2025 Q3 $4.6M $14.2M -$0.04 -$0.07 $0.03
08/06/2025 Q2 $4.9M $28.9M $0.01 -$0.08 $0.09
05/13/2025 Q1 $1.2M $1.3M -$0.07 -$0.10 $0.03
03/06/2025 Q4 $6.5M $26.6M -$0.09 -$0.12 $0.03
11/12/2024 Q3 $2.9M $1.8M -$0.18 -$0.17 -$0.01
08/01/2024 Q2 $3.4M $1.6M -$0.17 -$0.19 $0.01
05/02/2024 Q1 $1.4M $1.1M -$0.20 -$0.20 $0.00
03/26/2024 Q4 $1.2M $702K -$0.20 -$0.23 $0.03
11/08/2023 Q3 -- $162K -$0.21 -- --
08/03/2023 Q2 -- $317K -$0.22 -- --
05/02/2023 Q1 -- $24K -$0.17 -- --
03/02/2023 Q4 -- $28K -$0.16 -- --
11/09/2022 Q3 -- $39K -$0.13 -- --
08/02/2022 Q2 -- $35K -$0.16 -- --
05/05/2022 Q1 -- $37K -$0.16 -- --
02/28/2022 Q4 -- $14K -$0.17 -- --
11/03/2021 Q3 -- $23K -$0.16 -- --
07/30/2021 Q2 -- $234K -$0.13 -- --
05/06/2021 Q1 -- $27K -$0.15 -- --
03/10/2021 Q4 -- $199K -$0.04 -- --
10/29/2020 Q3 -- $6.6M $0.70 -- --
07/30/2020 Q2 -- $9.2M -$0.65 -- --
04/27/2020 Q1 -- $8M -$0.63 -- --
03/12/2020 Q4 -- $8.7M -$0.48 -- --
11/07/2019 Q3 -- $294.4M $1.95 -- --
08/01/2019 Q2 -- $9.7M -$0.22 -- --
05/01/2019 Q1 -- $9.2M -$0.21 -- --
03/13/2019 Q4 -- $17.1M -$0.16 -- --
11/01/2018 Q3 -- $7M -$0.26 -- --
07/30/2018 Q2 -- $13.8M -$0.33 -- --
05/03/2018 Q1 -- $25.4M -$0.40 -- --
02/22/2018 Q4 -- $33M -$0.27 -- --
11/08/2017 Q3 -- $26.9M -$0.29 -- --
08/01/2017 Q2 -- $12.1M -$0.33 -- --
05/02/2017 Q1 -- $18.3M -$0.33 -- --
03/03/2017 Q4 -- $23M -$0.31 -- --
11/01/2016 Q3 -- $27.7M -$0.35 -- --
08/04/2016 Q2 -- $20.1M -$0.37 -- --
05/03/2016 Q1 -- $12.5M -$0.34 -- --

Lexicon Pharmaceuticals, Inc. Earnings Questions

  • How Much did Lexicon Pharmaceuticals, Inc. Generate in Revenue Last Quarter?

    Lexicon Pharmaceuticals, Inc. reported $14.2M worth of top line sales in its most recent quarter.

  • Did Lexicon Pharmaceuticals, Inc. Beat Earnings Last Quarter?

    Lexicon Pharmaceuticals, Inc. announced earnings per share of -$0.04 which represents a beat of analyst forecast a -$0.07 per share.

  • Is Lexicon Pharmaceuticals, Inc. Profitable?

    Lexicon Pharmaceuticals, Inc. reported $14M that represents $0.04 per share over the last quarter.

  • What is the Analyst Consensus for Lexicon Pharmaceuticals, Inc. EPS Next Year?

    Lexicon Pharmaceuticals, Inc.'s earnings are forecast to decrease from -$0.63 per share to -$0.25 per share next year representing a decrease of -60.63%.

  • When is Lexicon Pharmaceuticals, Inc.'s Earnings Date?

    Lexicon Pharmaceuticals, Inc.'s next earnings date is March 5, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Is Sandisk The Next Big Memory Stock?
Is Sandisk The Next Big Memory Stock?

Computer memory manufacturer Sandisk (NASDAQ:SNDK) has quietly been one of…

Stock Ideas

Buy
51
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Sell
43
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 34x

Sell
44
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 28x

Alerts

Buy
77
CPS alert for Feb 14

Cooper-Standard Holdings, Inc. [CPS] is up 32.06% over the past day.

Buy
58
TPH alert for Feb 14

Tri Pointe Homes, Inc. [TPH] is up 26.83% over the past day.

Sell
20
IRON alert for Feb 14

Disc Medicine, Inc. [IRON] is down 21.88% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock